Opioid Receptor-Mediated Effects of Interleukin-2 on the [ca2+]i Transient and Contraction in Isolated Ventricular Myocytes of the Rat

Chun-Mei Cao,Qiang Xia,Ying-Ying Chen,Xiong Zhang,Yue-Liang Shen

DOI: https://doi.org/10.1007/s00424-001-0743-3

2001-01-01

Pflügers Archiv - European Journal of Physiology

Abstract:Cytokines play significant roles in some cardiovascular disorders, but direct myocardial effects of cytokines remain to be elucidated. In this study, we examined the effects and possible mechanisms of interleukin-2 (IL-2) on contraction and the [Ca2+]i transient of enzymatically isolated ventricular myocytes with spectrofluorometry and video tracking. IL-2 (2.5–200 U/ml) depressed both the contraction and the [Ca2+]i transient in a dose-dependent manner. Pretreatment with the universal opioid receptor antagonist naloxone (10 nM), or a specific κ opioid receptor antagonist, nor-binaltorphimine (nor-BNI, 10 nM), abolished the inhibitory effect of IL-2 on contraction and the [Ca2+]i transient; the specific δ-opioid receptor antagonist naltrindole (1 µM) had no effect. The effect of IL-2 was also abolished after pretreatment with pertussis toxin (PTX, 5 mg/l), but not by genistein (100 µM). Pretreatment with the phospholipase C inhibitor U73122 (5 µM) significantly inhibited the IL-2-induced depression of contraction and the [Ca2+]i transient. It is concluded that the effects of IL-2 on contraction and the [Ca2+]i transient of ventricular myocytes are mediated via the cardiac κ opioid receptor, and the postreceptor signal transduction pathway includes a PTX-sensitive G protein and phospholipase C.